BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gouard S, Maurel C, Marionneau-Lambot S, Dansette D, Bailly C, Guérard F, Chouin N, Haddad F, Alliot C, Gaschet J, Eychenne R, Kraeber-Bodéré F, Chérel M. Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease. Cancers (Basel) 2020;12:E2721. [PMID: 32971984 DOI: 10.3390/cancers12092721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li F, Yang Y, Liao J, Liu N. Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.025] [Reference Citation Analysis]
2 Eychenne R, Chérel M, Haddad F, Guérard F, Gestin JF. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight". Pharmaceutics 2021;13:906. [PMID: 34207408 DOI: 10.3390/pharmaceutics13060906] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Berdal M, Gouard S, Eychenne R, Marionneau-Lambot S, Croyal M, Faivre-Chauvet A, Chérel M, Gaschet J, Gestin JF, Guérard F. Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chem Sci 2020;12:1458-68. [PMID: 34163909 DOI: 10.1039/d0sc05191h] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
4 Guérard F, Maingueneau C, Liu L, Eychenne R, Gestin JF, Montavon G, Galland N. Advances in the Chemistry of Astatine and Implications for the Development of Radiopharmaceuticals. Acc Chem Res 2021. [PMID: 34350753 DOI: 10.1021/acs.accounts.1c00327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]